ArticleScience advances2019

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease.

Jong-Hyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.